for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Davita Inc

DVA.N

Latest Trade

72.69USD

Change

0.06(+0.08%)

Volume

32,770

Today's Range

72.45

 - 

72.80

52 Week Range

43.40

 - 

73.50

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
72.63
Open
72.63
Volume
32,770
3M AVG Volume
36.81
Today's High
72.80
Today's Low
72.45
52 Week High
73.50
52 Week Low
43.40
Shares Out (MIL)
128.11
Market Cap (MIL)
9,263.76
Forward P/E
13.85
Dividend (Yield %)
--

Next Event

DaVita Inc Extraordinary Shareholders Meeting

Latest Developments

More

Berkshire Hathaway Reports 29.7% Stake In Davita As Of Nov 7

Davita Inc Reports Qtrly Adjusted Net Income From Continuing Operations Per Share Of $1.53

Berkshire Hathaway Inc Reports 27.8% Stake In Davita Inc

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Davita Inc

DaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. The Company's segments include U.S. dialysis and related lab services and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as an end-stage renal disease (ESRD). In addition, as of March 31, 2019, the Company operated or provided administrative services to 243 outpatient dialysis centers located in nine countries outside of the United States.

Industry

Healthcare Facilities

Contact Info

2000 16th St

+1.310.5362668

https://www.davita.com/

Executive Leadership

Kent J. Thiry

Executive Chairman of the Board

Javier J. Rodriguez

Chief Executive Officer, Director

Joel Ackerman

Chief Financial Officer, Treasurer

John Winstel

Chief Accounting Officer, Group Vice President

James O. Hearty

Chief Compliance Officer

Key Stats

2.69 mean rating - 13 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

14.7K

2017

15.6K

2018

11.4K

2019(E)

11.4K
EPS (USD)

2016

3.850

2017

3.320

2018

3.570

2019(E)

5.221
Price To Earnings (TTM)
18.88
Price To Sales (TTM)
0.82
Price To Book (MRQ)
4.18
Price To Cash Flow (TTM)
6.46
Total Debt To Equity (MRQ)
350.90
LT Debt To Equity (MRQ)
345.66
Return on Investment (TTM)
6.10
Return on Equity (TTM)
4.47

Latest News

Latest News

UnitedHealth gets FTC approval for DaVita unit purchase

UnitedHealth Group Inc won anti-trust approval to buy DaVita Inc's primary and urgent care unit for $4.3 billion, the Federal Trade Commission said on Wednesday.

U.S. FTC approves UnitedHealth's proposed purchase of DaVita unit

UnitedHealth Group Inc won antitrust approval to buy DaVita Inc's primary and urgent care unit for $4.3 billion, the Federal Trade Commission said on Wednesday. (Reporting by Diane Bartz Editing by Leslie Adler)

DaVita unit to pay $270 million to resolve Medicare payments probe

A medical care unit of DaVita Inc <DVA.N> has agreed to pay $270 million to resolve claims it provided inaccurate information about patients that caused Medicare Advantage plans operated by private insurers to obtain inflated payments from the government.

DaVita resolves U.S. probe into Medicare payments for $270 mln

A medical care unit of DaVita Inc will pay $270 million to resolve claims it provided inaccurate information about patients that caused Medicare Advantage plans operated by private insurers to obtain inflated payments from the government.

U.S. jury orders DaVita to pay $383.5 million in wrongful death lawsuits

A federal jury in Colorado has awarded $383.5 million to the families of three patients who said they suffered cardiac arrests and died soon after receiving dialysis treatments at clinics run by DaVita Inc.

BRIEF-DaVita Reports Q1 Earnings Per Share $1.05 From Continuing Operations

* Q1 EARNINGS PER SHARE VIEW $0.93 -- THOMSON REUTERS I/B/E/S

BRIEF-DaVita Says CEO Kent Thiry's Total 2017 Compensation Was $15.3 Mln

* DAVITA INC SAYS CEO KENT THIRY'S TOTAL 2017 COMPENSATION WAS $15.3 MILLION VERSUS $12.3 MILLION IN 2016

BRIEF-Davita Inc Reports Q4 Earnings Per Share $0.85 From Continuing Operations

* Q4 ADJUSTED EARNINGS PER SHARE $0.92 FROM CONTINUING OPERATIONS

BRIEF-Davita Kidney Care Issues Statement About Davita Rx Settlement

* DAVITA KIDNEY CARE ISSUES STATEMENT ABOUT DAVITA RX SETTLEMENT

UPDATE 2-DaVita pharmacy unit settles U.S. billing probe for $63.7 million

A pharmacy services unit of DaVita Inc will pay $63.7 million to resolve allegations that it improperly billed federal healthcare programs for medications and paid illegal financial inducements to patients, the U.S. Justice Department said.

DaVita unit to pay $63.7 million to resolve U.S. billing probe

A pharmacy services unit of DaVita Inc has agreed to pay $63.7 million to resolve allegations that it improperly billed federal healthcare programs for medications and paid illegal financial inducements to patients, the U.S. Justice Department said.

UnitedHealth to buy DaVita primary care unit for $4.9 billion

The largest U.S. health insurer UnitedHealth Group Inc will buy DaVita Inc's primary and urgent care services for $4.9 billion in its second acquisition this year to expand its fast-growing medical group, it said on Wednesday.

Deals of the day-Mergers and acquisitions

The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:

UnitedHealth to buy DaVita's medical unit for $4.9 bln

UnitedHealth Group Inc said on Wednesday it would acquire kidney care services provider DaVita Inc's medical unit for about $4.9 billion in cash to expand its operations in ambulatory care services.

Exclusive: DaVita explores sale of physician network business -sources

DaVita Inc <DVA.N>, the largest U.S. provider of kidney care services, is exploring a sale of its physician network business, DaVita Medical Group, that could value the unit at up to $4 billion, according to people familiar with the matter.

Dialysis provider DaVita swings to loss on impairment charge

DaVita Inc <DVA.N>, the biggest U.S. dialysis services provider, swung to a third-quarter loss due to an impairment charge it took for the continued underperformance of its Medical Group healthcare delivery and management unit.

BRIEF-DaVita Inc. 3rd quarter 2017 results

* Q3 earnings per share view $0.94 -- Thomson Reuters I/B/E/S

Dialysis service provider DaVita posts quarterly loss

DaVita Inc on Tuesday reported a third-quarter loss, compared with a year-ago profit, due to higher expenses.

BRIEF-DaVita provides additional information regarding patients receiving charitable premium assistance

* DaVita provides additional information regarding patients receiving charitable premium assistance

BRIEF-Davita provides disclosures regarding charitable premium assistance

* Davita provides disclosures regarding charitable premium assistance

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up